Effect of chronic glutathione deficiency on the behavioral phenotype of Gclm(-/-) knockout mice

Neurotoxicology and Teratology

Volumn 34, Issue 4, 2012, Pages 450-457

  Chen, Ying ^a,b   Curran, Christine P ^a,c   Nebert, Daniel W ^a   Patel, Krishna V ^a   Williams, Michael T ^a   Vorhees, Charles V ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NORTHERN KENTUCKY UNIVERSITY   (United States)

Author keywords

Acoustic startle response; Elevated zero maze; GSH; Locomotor activity; Morris water maze; Novel object recognition

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; HYPERACTIVITY; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; OXIDATIVE STRESS; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX; STIMULUS RESPONSE; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; FEMALE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS;

MUS;

EID: 84862634290     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.04.009     Document Type: Article

References (55)

1. Achat-Mendes C., Anderson K.L., Itzhak Y. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 2007, 32:531-541.
2. Amaro S., Planas A.M., Chamorro A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother 2008, 8:259-270.
3. Amato A., Connolly C.N., Moss S.J., Smart T.G. Modulation of neuronal and recombinant GABA(A) receptors by redox reagents. J Physiol 1999, 517(Pt 1):35-50.
4. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci 2008, 108:227-238.
5. Bailey K.R., Rustay N.R., Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. ILAR J 2006, 47:124-131.
6. 2+ channel currents requires a functional electron transport chain. J Biol Chem 2005, 280:21706-21712.
7. Chen Y., Shertzer H.G., Schneider S.N., Nebert D.W., Dalton T.P. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem 2005, 280:33766-33774.
8. Chen Y., Krishan M., Nebert D.W., Shertzer H.G. Glutathione-deficient mice are susceptible to TCDD-Induced hepatocellular toxicity but resistant to steatosis. Chem Res Toxicol. 2012, 25(1):94-100.
9. Chen Y., Curran C.P., Nebert D.W., Patel K.V., Williams M.T., Vorhees C.V. Effects of vitamin C deficiency during postnatal development on adult behavior: functional behavioral phenotype of Gulo(-/-) mice. Genes Brain Behav. 2012, 11(3):269-277.
10. Clark R.E., Zola S.M., Squire L.R. Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 2000, 20:8853-8860.
11. Clarke M.W., Burnett J.R., Croft K.D. Vitamin E in human health and disease. Crit Rev Clin Lab Sci 2008, 45:417-450.
12. Cole T.B., Giordano G., Co A.L., Mohar I., Kavanagh T.J., Costa L.G. Behavioral characterization of Gclm(-/-) knockout mice, a model for enhanced susceptibility to oxidative stress. J Toxicol 2011, 2011:157687.
13. Crawley J.N. What's wrong with my mouse?. Behavioral phenotyping of transgenic and knockout mice 2007, John Wiley & Sons, Hoboken, NJ.
14. Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron 2008, 57:809-818.
15. Curran C.P., Nebert D.W., Genter M.B., Patel K.V., Schaefer T.L., Skelton M.R., et al. In utero and lactational exposure to PCBs in mice: adult offspring show altered learning and memory depending on Cyp1a2 and Ahr genotypes. Environ Health Perspect 2011, 119:1286-1293.
16. Dalle-Donne I., Rossi R., Giustarini D., Colombo R., Milzani A. S-Glutathionylation in protein redox regulation. Free Radic Biol Med 2007, 43:883-898.
17. Dalton T.P., Shertzer H.G., Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 1999, 39:67-101.
18. Dalton T.P., Chen Y., Schneider S.N., Nebert D.W., Shertzer H.G. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med 2004, 37:1511-1526.
19. De Araujo D.P., Lobato R.F., Cavalcanti J.R., Sampaio L.R., Araujo P.V., Silva M.C., et al. Contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. Int J Neurosci 2011, 121:51-57.
20. Dhanasekaran M., Ren J. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res 2005, 2:447-459.
21. Diaz D., Krejsa C.M., Kavanagh T.J. Expression of glutamate-cysteine ligase during mouse development. Mol Reprod Dev 2002, 62:83-91.
22. Diaz D., Krejsa C.M., White C.C., Charleston J.S., Kavanagh T.J. Effect of methylmercury on glutamate-cysteine ligase expression in the placenta and yolk sac during mouse development. Reprod Toxicol 2004, 19:117-129.
23. dos Santos A.P., Milatovic D., Au C., Yin Z., Batoreu M.C., Aschner M. Rat brain endothelial cells are a target of manganese toxicity. Brain Res 2010, 1326:152-161.
24. Ehrman L.A., Williams M.T., Schaefer T.L., Gudelsky G.A., Reed T.M., Fienberg A.A., et al. Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes Brain Behav 2006, 5:540-551.
25. Fonnum F., Lock E.A. Contributions of excitotoxicity, glutathione depletion, and DNA repair in chemically induced injury to neurons: exemplified with toxic effects on cerebellar granule cells. J Neurochem 2004, 88:513-531.
26. Giordano G., Kavanagh T.J., Costa L.G. Neurotoxicity of a polybrominated diphenyl ether mixture (DE-71) in mouse neurons and astrocytes is modulated by intracellular glutathione levels. Toxicol Appl Pharmacol 2008, 232:161-168.
27. Grace C.E., Schaefer T.L., Herring N.R., Graham D.L., Skelton M.R., Gudelsky G.A., et al. Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol 2010, 32:346-355.
28. Harrison F.E., May J.M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 2009, 46:719-730.
29. Hashimoto K.I., Ueda S., Ehara A., Sakakibara S.I., Yoshimoto K., Hirata K. Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat. Neurosci Lett 2011, [E-pub Oct 28].
30. Iwazaki T., McGregor I.S., Matsumoto I. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. Neurosci Lett 2008, 435:113-119.
31. Ma J., Shaw V.E., Mitrofanis J. Does melatonin help save dopaminergic cells in MPTP-treated mice?. Parkinsonism Relat Disord 2009, 15:307-314.
32. Mãrtensson J., Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc Natl Acad Sci U S A 1991, 88:4656-4660.
33. McConnachie L.A., Mohar I., Hudson F.N., Ware C.B., Ladiges W.C., Fernandez C., et al. Glutamate-cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci 2007, 99:628-636.
34. McIlwain K.L., Merriweather M.Y., Yuva-Paylor L.A., Paylor R. The use of behavioral test batteries: effects of training history. Physiol Behav 2001, 73:705-717.
35. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacol Ther 1991, 51:155-194.
36. Monks T.J., Ghersi-Egea J.F., Philbert M., Cooper A.J., Lock E.A. Symposium overview: the role of glutathione in neuroprotection and neurotoxicity. Toxicol Sci 1999, 51:161-177.
37. Obulesu M., Dowlathabad M.R., Bramhachari P.V. Carotenoids and Alzheimer's Disease: an insight into therapeutic role of retinoids in animal models. Neurochem Int 2011, [Jun 7: [Epub ahead of print]].
38. Paylor R., Spencer C.M., Yuva-Paylor L.A., Pieke-Dahl S. The use of behavioral test batteries, II: effect of test interval. Physiol Behav 2006, 87:95-102.
39. Reiter R.J., Manchester L.C., Tan D.X. Neurotoxicants: free-radical mechanisms and melatonin protection. Curr Neuropharmacol 2010, 8:194-210.
40. Rice M.E., Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 1998, 82:1213-1223.
41. Ristoff E., Larsson A. Patients with genetic defects in the gamma-glutamyl cycle. Chem Biol Interact 1998, 111-112:113-121.
42. Schaefer T.L., Vorhees C.V., Williams M.T. Mouse plasmacytoma-expressed transcript-1 knockout-induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. Neuroscience 2009, 164:1431-1443.
43. Senft A.P., Dalton T.P., Shertzer H.G. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal Biochem. 2000, 280(1):80-86.
44. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 1994, 116:56-64.
45. Skelton M.R., Schaefer T.L., Graham D.L., Degrauw T.J., Clark J.F., Williams M.T., et al. Creatine transporter (CrT; Slc6a8) knockout mouse as a model of human CrT deficiency. PLoS One 2011, 6:e16187.
46. Steullet P., Cabungcal J.H., Kulak A., Kraftsik R., Chen Y., Dalton T.P., et al. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci 2010, 30:2547-2558.
47. Sucher N.J., Lipton S.A. Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J Neurosci Res 1991, 30:582-591.
48. Tang X.D., Xu R., Reynolds M.F., Garcia M.L., Heinemann S.H., Hoshi T. Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 2003, 425:531-535.
49. Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006, 79:586-592.
50. Trotti D., Nussberger S., Volterra A., Hediger M.A. Differential modulation of the uptake currents by redox interconversion of cysteine residues in the human neuronal glutamate transporter EAAC1. Eur J Neurosci 1997, 9:2207-2212.
51. Volterra A., Trotti D., Floridi S., Racagni G. Reactive oxygen species inhibit high-affinity glutamate uptake: molecular mechanism and neuropathological implications. Ann N Y Acad Sci 1994, 738:153-162.
52. Vorhees C.V. Design considerations in the use of behavioral test batteries for the detection of CNS dysfunction in laboratory animals. Ment Retard Dev Disabil Res Rev 1996, 2:227-233.
53. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1:848-858.
54. Yang Y., Dieter M.Z., Chen Y., Shertzer H.G., Nebert D.W., Dalton T.P. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem 2002, 277:49446-49452.
55. Zannoni V., Lynch M., Goldstein S., Sato P. A rapid micromethod for the determination of ascorbic acid in plasma and tissues. Biochem Med. 1974, 11(1):41-48. [Sep].